University of Hertfordshire

From the same journal

By the same authors

Multicenter, Randomized, Active Comparator-Controlled, Double-Blind, Double-Dummy, Parallel Group, Dose-Finding Phase 2 Study Comparing the Safety of the Oral FXIa Inhibitor Asundexian with Apixaban in Patients with Atrial Fibrillation

Research output: Contribution to journal › Article › peer-review

  • Jonathan P Piccini
  • Valeria Caso
  • Stuart J Connolly
  • Keith A A Fox
  • Jonas Oldgren
  • Schuyler Jones
  • Diana Gorog
  • Vaclav Durdil
  • Thomas Viethen
  • Christoph Neumann
  • Hardi Mundl
  • Manesh R Patel
View graph of relations
Original languageEnglish
JournalThe Lancet
Publication statusPublished - 3 Apr 2022

ID: 27115040